Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Medicus Pharma Appoints Faisal Mehmud As Chief Executive Officer of Antev

PUBLIC · MDCXAug 03, 2026•6 days ago

Position

Chief Executive Officer

Company

Medicus Pharma

Faisal Mehmud
TorontoBiotechnologyHealthcareTherapeutics

Description

Medicus Pharma has announced the appointment of Faisal Mehmud, MD, MRCP, as the Chief Executive Officer of Antev Limited, effective August 30, 2026. This appointment strengthens the integrated leadership structure of Medicus as they advance the global development of Teverelix®.

Company Information

Company

Medicus Pharma

Location

100 KING STREET WEST

Toronto, Ontario, Canada

About

Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets. The Company is currently advancing the clinical development program of its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC). Medicus is also developing Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer. D-MNA and Teverelix, collectively represent ~$8 billion in potential market opportunity.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Medicus Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.